MEDRAD partners with University of South Florida for PET imaging study

MEDRAD, a developer of medical devices for radiology, has signed a research agreement with the University of South Florida to study the impact of automated fluoro-deoxy-glucose administration on the workflow for positron emission tomography imaging procedures.

Clinicians at Moffitt Cancer Center in Tampa, Florida will utilize MEDRAD's Intego positron emission tomography (PET) infusion system to measure and infuse patient-specific fluoro-deoxy-glucose (FDG) doses while industrial engineers from University of South Florida gather and analyze workflow data.

The study is designed to compare manual infusion to automated infusion, and to quantify time, cost and labor savings that is expected to result from the process improvements enabled by automated FDG infusion.

According to MEDRAD, the Intego system improves workflow by eliminating manual steps in the preparation and handling of patient doses through design that incorporates a multi-dose FDG vial and dose-on-demand technology. Intego also provides safety and accuracy benefits by reducing radiation exposure from dose preparation and infusion by at least 20% and infusing FDG within plus or minus 2% of the measured dose, said MEDRAD.

Doug Descalzi, executive director at MEDRAD Molecular Imaging, said: "Intego improves workflow and saves time, compared to manual infusion. Intego workflow and process advantages are unique and can be significant contributors in a growing PET clinic's efforts to manage costs and drive utilization."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Related terms: cancer, clinic, executive, industrial, labor, medical, research, technology, university, workflow